10x Genomics (TXG) Misses Q1 EPS by 9c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
10x Genomics Reports First Quarter 2020 Financial Results
May 11, 2020 4:04 PM EDTPLEASANTON, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the quarter ended March 31, 2020.
Recent Highlights
Revenue of $71.9 million for the first quarter, representing a 34% increase over the corresponding period of 2019 Announced a broad range of new products and new capabilities at the Advances in Genome Biology and Technology (AGBT) Meeting in February Began shipping and completed initial placements of the Chromium Connect instrumentWe... More



